Inside the Triple Helix: Technology Transfer And Commercialization In The Life Sciences
The transfer and subsequent application of academic research results has demonstrable benefits for health care, researchers, universities, companies, and local economies. Nonetheless, at least three general concerns exist: bias in the reporting of results, limited revenues from these activities, and...
Saved in:
Published in | Health Affairs Vol. 23; no. 1; pp. 64 - 76 |
---|---|
Main Authors | , , , |
Format | Journal Article |
Language | English |
Published |
United States
Health Affairs
01.01.2004
The People to People Health Foundation, Inc., Project HOPE |
Subjects | |
Online Access | Get full text |
Cover
Loading…
Summary: | The transfer and subsequent application of academic research results has demonstrable benefits for health care, researchers, universities, companies, and local economies. Nonetheless, at least three general concerns exist: bias in the reporting of results, limited revenues from these activities, and the lack of data to evaluate technology transfer activities. Future efforts with regard to technology transfer in the life sciences will need to recognize its importance without ignoring concerns or overestimating benefits. Next steps include better monitoring of university-industry relationships, the development of a better data system, the dissemination of best practices in technology transfer management, and evaluation of national technology-transfer policies. |
---|---|
Bibliography: | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 |
ISSN: | 0278-2715 1544-5208 |
DOI: | 10.1377/hlthaff.23.1.64 |